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EDITORIAL
Risky business
A variety of factors may account for the high mortality and therefore did not include large numbers of patients
who began dialysis in Japan because not all centers sub-rate that characterizes the hemodialysis population.
These include co-morbid illnesses, the nutritional status mitted data. Unreported cases in Japan could be from
centers that had fewer resources and could conceivablyof the patient, the dialysis prescription and patient com-
pliance. Physician practices and the inability of current have had lower survival rates. No attempts were made
to do any validation studies with regard to the accuracydialysis practices to replace key yet unidentified func-
tions of the kidney that impact survival have also con- of the information in either registry. In addition, higher
acceptance rates in the U.S. (130 per 1,000,000 popula-cerned those who have focused upon dialysis outcomes.
tion) than in Japan (120 per 1,000,000 population) mightThere has been considerable variance in the recorded
have resulted in U.S. physicians treating patients withmortality rates in dialysis populations in different coun-
more serious co-morbid conditions who would not havetries. Specifically, a superior patient survival has been
necessarily been considered for dialysis in Japan. In com-described for the United States (U.S.) pediatric popula-
paring survival rates, only diabetes and age were ac-tion and for middle aged and elderly patients in Europe
counted for, leaving open the question of whether otherand Japan [1]. This variance in mortality rates between
measurable co-morbid factors may have contributed tocountries has been explored in order to determine
the differences in reported survival rates in these twowhether important factors that could be modified might
countries. Interestingly, in the same report, the authorsbe identified. Explanations for disparate mortality rates
looked at the differences in background mortality ratesin different countries might include a wide range of vari-
in the general populations of these two countries andables. Differences in background overall death rates in
found a lower mortality rate relative to the United Statesa specific population, in dialysis prescriptions and deliv-
displayed by the Japanese population at large. However,ery, in dialysis acceptance practices, in transplantation
the authors concluded that the Japanese end-stage renalrates, in local dietary habits, in co-morbid conditions, in
disease (ESRD) population had a relative risk of 1.33,body mass index (BMI), in environmental or regional
while the risk in the general population was only 1.21.exposures, in general medical care, or in genetic suscepti-
Also, since the authors were only analyzing survival andbility rates for complications in different populations
not specific causes of death, and had available only mini-have all been considered.
mum data on age and diabetes as co-morbid factors, theyA detailed report examined the mortality rates in dial-
were unable to comment on many of the other possibleysis patients in the U.S., Japan and Europe and found
explanations for the reported differences in survival inthat the five-year survival probability was 54% in Japan
the U.S. and Japanese ESRD populations. Despite allas compared to 39% in the U.S. [1]. This 15% point
the limitations of the data that was used to generatedifferential between the American and Japanese patients
the report and limitations of the variables that wererepresented a relative risk of greater mortality of 33%.
examined, this publication prompted much concern. ItU.S. patients with diabetic nephropathy had a lower sur-
was speculated that the differences in survival in thesevival rate than Japanese patients with diabetes. The data
populations might be accounted for by differences inused for the analysis was based upon registry reports by
dialysis prescriptions in the U.S. compared to dialysisthe Japanese Society for Dialysis Therapy and by the
prescriptions in Japan. Many went on to speculate thatU.S. Renal Data System (USRDS). In point of fact, the
the differences in the methods of reimbursement forinformation that was analyzed came from two dramati-
dialysis in the two countries led to U.S. patients beingcally different sources, thus severely limiting the inter-
delivered an “inferior dialysis product.” Although thispretation of the data. The U.S. data had the strength of
was expressed as a concern, in fact, the report did notregistering over 90% of treated patients, but its weakness
examine or document differences in dialysis treatmentwas in excluding patients who had a mortal event in the
times or other aspects of the prescription between thefirst 90 days after initiating dialysis. The Japanese Society
two countries or correlate any such differences to out-for Dialysis Therapy did not require outcome reports,
come. Patient compliance was also suggested to be a
possible explanation, again, with the undocumented bias
that Japanese patients were more punctual and compli-
ant than U.S. dialysis patients. 1999 by the International Society of Nephrology
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In this issue of Kidney International, the article by general population, death rates that were available to
them as in the previous report (at least one of the authorsWong et al allows the data in the previous report to be
viewed in a somewhat different light [2]. This study has in these two reports is the same) this may be explained
in part by looking at a half full versus a half empty glassa major advantage because the patients being compared
all had data collected similarly by the USRDS, so there of water philosophy. In the previous publication, the
general population death rate was a contributing factorwere no data biases introduced by different kinds of
registries as in the previous report. Since the USRDS but did not account for the entire difference, which is,
of course, similarly true in this study in the current issuecollects many important additional factors other than
just survival, the authors were able to adjust for these of Kidney International.
This report is somewhat reassuring that Asian Ameri-in their analysis. Importantly, they found that adjusting
for demographics, diabetes, co-morbidities and nutri- cans living in the U.S. and receiving dialysis presumably
retain their survival advantage, suggesting that differ-tional factors, a relative mortality risk for Asian Ameri-
cans on dialysis was 0.75 relative to Caucasians on dial- ences in survival previously reported between the Japa-
nese and U.S. populations is not as likely to be accountedysis (P 5 0.0001). Although Asians only make up 3.5%
of the U.S. incident dialysis population compared to Cau- for by differences in the U.S. dialysis delivery system.
Although reassuring, it should not slow efforts to im-casians (whites) who represent 63.3%, this still repre-
sents a large data set of 4,471 Asian Americans with prove overall survival. It is unlikely that the difference
in Asian American versus white American survival isESRD. The Asian Americans had fewer co-morbid con-
ditions except for diabetes. Also, interestingly, there was completely accounted for by genetic factors or the death
rates in the background population alone. Almost cer-a survival advantage even for Asian Americans who had
diabetes compared to whites with diabetes. This may tainly there are variables that are different for Asian
Americans such as nutrition, compliance and even dial-reflect the difference in the nature of diabetes and its
complications in Asians. Cross-sectional studies from ysis prescription, variables that, if identified and modified
in the population as a whole, could lead to a beneficialEngland revealed that although equal numbers of whites
and Asians had abnormal glucose tolerance tests, more effect.
The initial report and the study in this issue highlightAsians had diabetes than whites [3]. There was a shorter
duration of diabetes reported in Asian Americans with the strengths and weaknesses of epidemiologic analyses
which, by their nature, cannot account for or control anephropathy, suggesting that Asian Americans may
move from glucose intolerance to frank diabetes with wide variety of variables and are limited by the nature
of the data collected. Hasty speculations to account forcomplications in a shorter period of time. Although
Asians in England are reported to have an increased the data in these epidemiologic analyses are a risky busi-
ness.incidence of renal disease compared to the white popula-
tion, they have a decreased incidence of peripheral vascu-
Julia Breyer-Lewislar disease and retinopathy [4]. These data suggest that
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increase mortality rates once they reach ESRD.
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